ACM
TWST icon

Aster Capital Management’s Twist Bioscience TWST Stock Holding History

Aster Capital Management’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1
Closed -$32 – 1339
2025
Q4 		$32 Buy
+1
New +$31 ﹤0.01% 1051
2025
Q2 		– Sell
-299
Closed -$11.6K – 1586
2025
Q1 		$11.6K Buy
+299
New +$13.5K ﹤0.01% 1049

Other funds holding TWST

Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Aster Capital Management's TWST Position: Q1 2026 in Review

Aster Capital Management sold out of Twist Bioscience (TWST) in Q1 2026, closing a stake of 1 share — an estimated $32 sold.

Aster Capital Management first reported a position in TWST in Q1 2025 and held it in 2 quarters. The position peaked at $11.6K in Q1 2025. 280 funds tracked by Wall St. Rank hold TWST as of Q1 2026.

  • Aster Capital Management reported no remaining Twist Bioscience position as of Q1 2026 after selling out during the quarter.
  • Aster Capital Management sold 1 Twist Bioscience share in Q1 2026, an estimated $32.
  • Aster Capital Management first reported a position in Twist Bioscience in Q1 2025 and held it in 2 quarters.
  • Aster Capital Management's Twist Bioscience position peaked at $11.6K in Q1 2025.
  • 280 funds tracked by Wall St. Rank held Twist Bioscience as of Q1 2026.

Based on Aster Capital Management's 13F filing for Q1 2026, filed 13 May 2026.